Guggenheim Assumes Buy Rating on Relay Therapeutics with PT of $15

Thursday, Sep 4, 2025 10:20 am ET1min read
RLAY--

Guggenheim Assumes Buy Rating on Relay Therapeutics with PT of $15

Guggenheim Assumes Buy Rating on Relay Therapeutics with PT of $15

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet